CLP36, a protein known for its involvement in cytoskeletal organization and cellular morphology, plays a critical role in the regulation of actin filament assembly and disassembly, anchoring proteins in specific cellular locations, and facilitating cell signaling pathways that are essential for cell adhesion, migration, and proliferation. It functions as part of a complex network of proteins that interact with the actin cytoskeleton, serving as a scaffold for assembling protein complexes that regulate the dynamics of actin filaments. Through its interactions, CLP36 influences the structural integrity of cells and is involved in the processes that determine cell shape and movement. Its activity and localization within the cell are tightly regulated by various signaling molecules and pathways, reflecting its importance in maintaining cellular architecture and responding to environmental cues.
The inhibition of CLP36 involves the disruption of its normal function in the actin cytoskeleton organization and cell signaling. Inhibitors of CLP36 typically target the protein's ability to bind to actin or its partner proteins, thereby altering the assembly of actin filaments and affecting cell morphology and motility. The mechanisms of inhibition can vary, including the direct binding of inhibitory molecules to CLP36, which prevents its interaction with actin or other regulatory proteins, or the modulation of signaling pathways that control CLP36's activity and localization. Such inhibition can lead to significant changes in cell behavior, including alterations in cell adhesion, migration, and potentially affecting the processes of cell division and differentiation. The study of CLP36 and its inhibition offers valuable insights into the complex regulation of the cytoskeleton and its impact on cellular functions, highlighting the intricate balance of protein interactions that sustain cellular organization and dynamics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor that can alter the actin cytoskeleton organization and potentially affect the function of CLP36 which is involved in cytoskeletal organization. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
An inhibitor of myosin light chain kinase (MLCK) which is involved in actin-myosin contraction and could indirectly influence the cytoskeletal role of CLP36. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Inhibits myosin II activity and thus may impact cytoskeletal dynamics that CLP36 is a part of. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin polymerization and could affect the structural roles of CLP36 in maintaining the actin cytoskeleton. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments and could perturb the balance of actin dynamics that CLP36 is associated with. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor, leading to disruptions in calcium homeostasis, potentially affecting CLP36-related signaling pathways. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
A calmodulin antagonist that could disrupt calcium signaling, indirectly affecting the function of CLP36. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Binds to actin monomers and prevents polymerization, potentially impacting the role of CLP36 in the cytoskeleton. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
An Arp2/3 complex inhibitor which could affect actin filament branching and indirectly the role of CLP36. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
Inhibits formin-mediated actin nucleation and elongation, potentially impacting the cytoskeletal interactions of CLP36. | ||||||